12 Health Care Stocks Moving In Monday's Intraday Session


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Gainers

  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares moved upwards by 283.5% to $1.3 during Monday's regular session. Trading volume for this security as of 13:30 EST is 20.3 million, which is 10431.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $69.7 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) shares rose 120.41% to $1.63. Trading volume for this security as of 13:30 EST is 115.9 million, which is 46986.9% of its average full-day volume over the last 100 days. The company's market cap stands at $104.5 million. As per the news, the Q2 earnings report came out today.
  • Virios Therapeutics (NASDAQ:VIRI) stock rose 26.57% to $1.09. As of 13:30 EST, this security is trading at a volume of 1.5 million shares, making up 190.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.2 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Humacyte (NASDAQ:HUMA) shares rose 18.5% to $3.88. The current volume of 1.1 million shares is 234.4% of Humacyte's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $400.7 million. As per the press release, Q2 earnings came out today.
  • OKYO Pharma (NASDAQ:OKYO) stock increased by 17.78% to $1.59. Trading volume for this security as of 13:30 EST is 56.0K, which is 47.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.6 million.
  • Summit Therapeutics (NASDAQ:SMMT) shares increased by 15.98% to $2.0. As of 13:30 EST, Summit Therapeutics's stock is trading at a volume of 1.9 million, which is 104.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion. As per the news, the Q2 earnings report came out 3 days ago.

Losers

  • BioXcel Therapeutics (NASDAQ:BTAI) stock fell 38.9% to $4.52 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 7.7 million shares, making up 290.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $131.7 million. As per the press release, Q2 earnings came out today.
  • Concord Medical Services (NYSE:CCM) shares fell 16.98% to $1.13. The market value of their outstanding shares is at $49.0 million.
  • Science 37 Hldgs (NASDAQ:SNCE) stock decreased by 16.6% to $0.37. As of 13:30 EST, this security is trading at a volume of 1.7 million shares, making up 114.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $42.9 million. As per the press release, Q2 earnings came out 4 days ago.
  • Oncology Institute (NASDAQ:TOI) stock fell 15.47% to $0.82. Trading volume for Oncology Institute's stock is 507.0K as of 13:30 EST. This is 56.7% of its average full-day volume over the last 100 days. The company's market cap stands at $59.8 million. The company's, Q2 earnings came out 4 days ago.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock declined by 14.79% to $0.75. AcelRx Pharmaceuticals's stock is trading at a volume of 374.3K shares as of 13:30 EST. This is 304.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.1 million. As per the press release, Q2 earnings came out 2 days ago.
  • Hillstream BioPharma (NASDAQ:HILS) stock decreased by 14.76% to $0.27. Trading volume for Hillstream BioPharma's stock is 367.8K as of 13:30 EST. This is 118.4% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: MoversBZI-TFM